Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current HIV/AIDS Reports|September 12, 2020
Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TBElisa H Ignatius, Susan Swindells
Clinics in Chest Medicine|November 17, 2019
New Drugs for the Treatment of TuberculosisElisa H Ignatius, Kelly E Dooley
The Journal of Clinical Investigation|September 28, 2020
Getting to the point in point-of-care diagnostics for tuberculosisElisa H Ignatius, Keira A Cohen, William R Bishai
Journal of Pharmaceutical and Biomedical Analysis|January 6, 2021
A validated liquid chromatography tandem mass spectrometry assay for the analysis of pretomanid in plasma samples from pulmonary tuberculosis patientsAndisiwe Malo, Tracy Kellermann, Elisa H Ignatius, et al.
Msphere|July 9, 2024
Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung diseaseElisa H Ignatius, Binayak Rimal, Chandra M Panthi, et al.
AIDS Care|August 26, 2020
PrEParing for long-acting injectable PrEP in the South: perspectives from healthcare providers in GeorgiaCasey D Xavier Hall, Justin C Smith, Robert A Driggers, et al.
Antimicrobial Agents and Chemotherapy|November 24, 2020
Pretomanid Pharmacokinetics in the Presence of Rifamycins: Interim Results from a Randomized Trial among Patients with TuberculosisElisa H Ignatius, Mahmoud Tareq Abdelwahab, Bronwyn Hendricks, et al.
Tuberculosis (Edinburgh, Scotland)|February 16, 2024
Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus diseaseBinayak Rimal, Chandra M Panthi, Yi Xie, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 2022
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week ResultsKelly E Dooley, Bronwyn Hendricks, Nikhil Gupte, et al.
Msphere|March 13, 2023
Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus DiseaseBinayak Rimal, Danielle A Nicklas, Chandra M Panthi, et al.
Pageof 2